Diet, microbes, and host genetics: The perfect storm in inflammatory bowel diseases

Journal of Gastroenterology

Volumn 48, Issue 3, 2013, Pages 315-321

  Leone, Vanessa ^a   Chang, Eugene B ^a   Devkota, Suzanne ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Gut microbiota; Inflammatory bowel diseases; Pathobiont; Western diet

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

CARBOHYDRATE INTAKE; CORRELATION ANALYSIS; DIET; DIETARY INTAKE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ETIOLOGY; FAT INTAKE; GENETIC ASSOCIATION; GENETIC DRIFT; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HOST PATHOGEN INTERACTION; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; ENTERITIS; GENETIC PREDISPOSITION; GENETICS; INTESTINE; METAGENOME; MICROBIOLOGY;

DIET; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; METAGENOME;

EID: 84884650652     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0777-2     Document Type: Review

References (50)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444: 860-7.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin. 2005;55: 74-108.
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126: 1504-17.
4. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142: 46-54.
5. Ogden C, Carroll MD, Kit BK, et al. Obesity in the United States, 2009-2010. NCHS Data Brief. 2012;82: 1-7.
6. Kirsner JB. The 'idiopathic' inflammatory bowel diseases: their cause and pathogenesis. Arch Dermatol. 1982;118: 280-2.
7. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28: 255-81.
8. Montgomery SM, Ekbom A. Epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18: 416-20.
9. de Souza RJ, Swain JF, Appel LJ, et al. Alternatives for the macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations. Am J Clin Nutr. 2008;88: 1-11.
10. Turnbaugh P, Bäckhed F, Fulton L, et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3: 213-23.
11. Turnbaugh P, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2008;1: 6-14.
12. Hildebrandt MA, Hoffman C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137: 1716-24.
13. Walter J, Ley R. The human gut microbiome; ecology and recent evolutionary changes. Annu Rev Microbiol. 2010;65: 411-29.
14. Chapman-Kiddell CA, Davies PSW, Gillen L, et al. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2010;16: 137-51.
15. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106: 563-73.
16. Lepage P, Seksik P, Sutren M, et al. Biodiversity of the mucosaassociated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis. 2006;11: 473-80.
17. Abdo Z, Shuette UM, Bent SJ, et al. Statistical methods for characterizing diversity of microbial communities by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes. Environ Microbiol. 2006;8: 929-38.
18. Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacol Ther. 2011;130: 202-12.
19. Monsen U, Bernell O, Johansson C, et al. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol. 1991;26: 302-6.
20. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29: 990-6.
21. Khor TO, Huang MT, Kwon KH, et al. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474: 307-17.
22. Ogura T, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411: 603-6.
23. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science. 2005;307: 734-8.
24. Gearry R, Roberts RL, Burt MJ, et al. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis. 2007;13: 1220-7.
25. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70: 845-57.
26. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314: 1461-3.
27. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39: 207-11.
28. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn's disease. Nat Genet. 2004;36: 471-5.
29. Gould SJ. The structure of evolutionary theory. Cambridge: Harvard University Press; 2002.
30. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81: 341-54.
31. Boaz NT. Evolving health: the origins of illness and how the modern world is making us sick. New York: Wiley; 2002.
32. Eaton SB, Konner MJ. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985;312: 283-9.
33. Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84: 739-49.
34. Frassetto L, Morris RC Jr, Sellmeyer DE, et al. Diet, evolution and aging-the pathophysiologic effects of the postagricultural inversion of the potassium-to sodium and base-to-chloride ratios in the human diet. Eur J Nutr. 2001;40: 200-13.
35. Backhed F, Ley RE, Sonnenberg JL, et al. Host-bacterial mutualism in the human intestine. Science. 2005;307: 1915-20.
36. Devkota SD, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;487: 104-8.
37. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest. 2004;113: 1296-306.
38. Hoentjen F, Sartor RB, Ozaki M, et al. STAT3 regulates NF-jB recruitment to the IL-12p40 promoter in dendritic cells. Blood. 2005;105: 689-96.
39. MacPherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996;38: 365-75.
40. Mizoguchi E, Mizoguchi A, Chiba C, et al. Anti-neutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology. 1997;113: 1828-35.
41. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology. 2004;126: 1620-33.
42. Cong Y, Weaver CT, Lazenby A, et al. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol. 2002;169: 6112-9.
43. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66: 5224-31.
44. Kullberg MC, Ward JM, Gorelick PL, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)- deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun. 1998;66: 5157-66.
45. Kim SC, Tonkonogy SL, Albright CA, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 2005;128: 891-906.
46. Sartor RB. Microbial influences in inflammatory bowel disease: role in pathogenesis and clinical implications. In: Sartor RB, Sandborn WJ, editors. Kirsner's inflammatory bowel diseases. Philadelphia: Elsevier; 2004. p. 138-62.
47. Moran JP, Walter J, Tannock GW, et al. Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm Bowel Dis. 2009;15: 1022-31.
48. Dieleman LA, Goerres MS, Arends A, et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003;52: 370-6.
49. Erickson AR, Cantarel BL, Lamendella R, et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE. 2012;7:e49138.
50. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.